Lucid Diagnostics (LUCD), a subsidiary of PAVmed (PAVM), announced that it has entered into its first concierge medicine contract with LEAA Health. The contract provides LEEA Health’s membership-based patients access to groundbreaking esophageal precancer testing using Lucid’s EsoGuard Esophageal DNA Test. This expands LEAA Health’s enhanced personalized care services, which it offers to its patients on a cash-pay basis.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LUCD: